USD 6.02
(-1.95%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 2.87 Million USD | 59.94% |
2022 | 1.79 Million USD | 64.53% |
2021 | 1.09 Million USD | -9.31% |
2020 | 1.2 Million USD | -15.7% |
2019 | 1.42 Million USD | 39.63% |
2018 | 1.02 Million USD | 87.87% |
2017 | 544 Thousand USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 2.1 Million USD | -26.85% |
2024 Q2 | 2.87 Million USD | 36.86% |
2023 Q4 | 2.87 Million USD | 28.23% |
2023 Q1 | 1.73 Million USD | -3.29% |
2023 Q3 | 2.23 Million USD | 35.45% |
2023 Q2 | 1.65 Million USD | -4.78% |
2023 FY | 2.87 Million USD | 59.94% |
2022 Q2 | 1.98 Million USD | 0.46% |
2022 Q4 | 1.79 Million USD | 31.6% |
2022 FY | 1.79 Million USD | 64.53% |
2022 Q3 | 1.36 Million USD | -31.28% |
2022 Q1 | 1.97 Million USD | 81.12% |
2021 Q1 | 2.17 Million USD | 80.96% |
2021 Q2 | 2.18 Million USD | 0.41% |
2021 FY | 1.09 Million USD | -9.31% |
2021 Q3 | 1.39 Million USD | -36.18% |
2021 Q4 | 1.09 Million USD | -21.79% |
2020 Q1 | - USD | -100.0% |
2020 FY | 1.2 Million USD | -15.7% |
2020 Q4 | 1.2 Million USD | 22.38% |
2020 Q3 | 983 Thousand USD | -36.7% |
2020 Q2 | 1.55 Million USD | 0.0% |
2019 Q1 | 1.00 USD | -100.0% |
2019 FY | 1.42 Million USD | 39.63% |
2019 Q2 | 940 Thousand USD | 93999900.0% |
2019 Q4 | 1.42 Million USD | 55.79% |
2019 Q3 | 916 Thousand USD | -2.55% |
2018 Q4 | 1.02 Million USD | 0.0% |
2018 FY | 1.02 Million USD | 87.87% |
2017 FY | 544 Thousand USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | -100.0% |
2014 Q1 | 1.00 USD | 0.0% |
2014 FY | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aclaris Therapeutics, Inc. | - USD | -Infinity% |
Applied DNA Sciences, Inc. | 330.02 Thousand USD | -769.929% |
Aspira Women's Health Inc. | 227 Thousand USD | -1164.758% |
Biodesix, Inc. | 1.4 Million USD | -105.071% |
BioNexus Gene Lab Corp. | 1.13 Million USD | -152.336% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | -15432.352% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | -15432.352% |
Bionano Genomics, Inc. | 22.89 Million USD | 87.459% |
CareDx, Inc | 19.47 Million USD | 85.255% |
Check-Cap Ltd. | - USD | -Infinity% |
Castle Biosciences, Inc. | 7.94 Million USD | 63.85% |
DarioHealth Corp. | 5.06 Million USD | 43.283% |
Exact Sciences Corporation | 127.47 Million USD | 97.748% |
Fulgent Genetics, Inc. | 5.82 Million USD | 50.729% |
Guardant Health, Inc. | 61.94 Million USD | 95.365% |
ICON Public Limited Company | 1.00 USD | -287099900.0% |
IDEXX Laboratories, Inc. | 380.28 Million USD | 99.245% |
Illumina, Inc. | 587 Million USD | 99.511% |
Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -269.243% |
iSpecimen Inc. | - USD | -Infinity% |
Standard BioTools Inc. | 20.53 Million USD | 86.018% |
MDxHealth SA | 2.77 Million USD | -3.311% |
23andMe Holding Co. | 12.46 Million USD | 76.968% |
Medpace Holdings, Inc. | 1.00 USD | -287099900.0% |
Myriad Genetics, Inc. | 20.1 Million USD | 85.716% |
Mainz Biomed B.V. | 613.63 Thousand USD | -367.865% |
ENDRA Life Sciences Inc. | 2.62 Million USD | -9.46% |
NeoGenomics, Inc. | 24.15 Million USD | 88.115% |
Neogen Corporation | 189.26 Million USD | 98.483% |
Inotiv, Inc. | 56.1 Million USD | 94.883% |
Natera, Inc. | 40.75 Million USD | 92.956% |
OPKO Health, Inc. | 65.69 Million USD | 95.63% |
Psychemedics Corporation | 1.00 USD | -287099900.0% |
Prenetics Global Limited | 3.12 Million USD | 8.18% |
Prenetics Global Limited | 3.12 Million USD | 8.18% |
Precipio, Inc. | 384 Thousand USD | -647.656% |
Personalis, Inc. | 5.66 Million USD | 49.285% |
RadNet, Inc. | 1.00 USD | -287099900.0% |
Sera Prognostics, Inc. | - USD | -Infinity% |
Sotera Health Company | 51.98 Million USD | 94.477% |
Neuronetics, Inc. | 8.09 Million USD | 64.525% |
Star Equity Holdings, Inc. | 3.42 Million USD | 16.053% |
Star Equity Holdings, Inc. | 3.42 Million USD | 16.053% |
Trinity Biotech plc | 19.93 Million USD | 85.597% |
Twist Bioscience Corporation | 32.06 Million USD | 91.046% |